Procedures for investigating cases of alleged misconduct in research 2024-25
c) Any breach of data protection legislation and failure to properly handle privileged, personal or private information collected during the research.
sign a Confidentiality and Conflicts of Interest Declaration, and will not have the right to interfere or exert any direct or indirect influence on the work of the Lead Investigator/members of the Screening Panel.
sign a Confidentiality and Conflicts of Interest Declaration, and will not have the right to interfere or exert any direct or indirect influence on the work of the Investigation Panel.
The Director of Legal Services.
b) Where the allegation is not upheld, and depending on the seriousness of the allegation, appropriate restorative actions should be recommended by the Panel to support the reputation of the Respondent and any relevant research project(s).
c) Where the Panel concludes that the allegation is malicious, vexatious or frivolous, it should make a recommendation whether disciplinary action should be considered against those who made the allegation (if members of the University). Where the Complainant is a member of another University or research organisation, the Panel should (with advice from Legal Services) make a recommendation whether the relevant university/research organisation should be contacted and informed about the allegations that were found to be malicious, vexatious or frivolous.
17.9 The Investigation Panel’s draft Report will be shared with the Vice-President (Research and Enterprise) who must decide, normally within 10 working days, whether or not to accept the recommendations made.
17.10 The Vice-President (Research and Enterprise) should communicate his decision and provide a copy of the Panel’s draft Report to the Complainant and the Respondent for them to comment on the factual accuracy of the Report. The Panel’s Report is strictly confidential and its content, or the Report itself, must not be shared with anybody without the permission of the University. Only when the Report includes any errors of fact, should the Investigation Panel modify the Report where appropriate.
17.11 The copy of the final Report should be provided to the Respondent and the Complainant, and other relevant parties where required.
17.12 Any corrective actions that need to be implemented and completed, should be overseen by the Vice-President (Research and Enterprise) with the support of the RIG Team and/or other relevant individuals as designated by the Vice-President (Research and Enterprise).
17.13 If the case has received publicity, the University should, where appropriate, issue an official statement/press release to make the outcome of the investigation public.
18. Sanctions
18.1 Appropriate action, which may include disciplinary action, may be taken against:
18.1.1 The Respondent where the allegation of research misconduct was upheld in accordance with this Procedure.
18.1.2 Anyone whose allegation of research misconduct was found to be malicious, vexatious or frivolous.
18.2 Disciplinary action
18.2.1 Any disciplinary action must be taken under the University’s disciplinary policy.
18.2.2 Where formal disciplinary action is taken under the University’s disciplinary policy, evidence gathered in the course of the research misconduct investigation, including formal Reports, will be used at the investigation stage of the disciplinary procedure.
19. Appeals
19.1 The Respondent and the Complainant cannot appeal against the decision made by the Vice President (Research and Enterprise) following a recommendation by the Lead Investigator/the Investigation Panel. The right to appeal only exists under the University’s disciplinary procedure in cases where this was recommended and instigated.
20. Procedure Review
20.1 This Procedure will be reviewed regularly in the light of any new available guidance or forthcoming legislation and at least once every three years.
21. Appendix A
Statement on dealing with Allegations of Research Misconduct under United States Public Health Service (USPHS) Research-related Activities for Foreign Institutions.
The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 has incorporated into its policies and procedures the following approach for dealing with and reporting possible research misconduct when USPHS funds are involved.
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 will designate an official to receive allegations and develop procedures for use by research employees or others who wish to make an allegation of research misconduct involving USPHS funds. The designated official will notify the U.S. Office of Research Integrity (ORI) when an allegation of research misconduct involving USPHS funds is received. Phone: (240) 453-8800. Fax: (301) 594-0043. Email: askORI@osophs.dhhs.gov
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 will then work with ORI or other appropriate offices of the U.S. Department of Health and Human Services (NHS) to develop and implement a process for responding to the research misconduct allegation that is consistent with U.S. Federal Regulation, 42 CFR Parts 50 and 93.
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 will submit appropriate reports (in English) to ORI that describe the process followed in conducting the investigation, the evidence on which the conclusions of the investigation are based, and if a finding of research misconduct is made, the administrative actions that are taken against the respondent.
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 will inform research employees about the official who is designated to receive allegations and the procedures for the employee or other individuals to make an allegation of research misconduct involving USPHS supported research. This information will also be posted on the organisation’s web site.
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 certifies that this statement will be a permanent amendment to the institution’s procedures for responding to allegations of research misconduct.
- The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 will submit the ‘Annual Report on Possible Research Misconduct’ to ORI by April 30th of each year. The report is submitted electronically through the ORI web site at http://ori.hhs.gov
Name of Organisation: University of 天发娱乐棋牌_天发娱乐APP-官网|下载
Address: Highfield Campus, University Road, 天发娱乐棋牌_天发娱乐APP-官网|下载, SO17 1BJ, United Kingdom
Phone: (+44) 2380 595000
Responsible Official’s Title: Head of Research Integrity and Compliance Office, Head of Contracts, Policy and Governance, Research and Innovation Services.
22. Acknowledgements
The University of 天发娱乐棋牌_天发娱乐APP-官网|下载 gratefully acknowledges that the following documents were referred to when preparing this Procedure:
ALLEA, 2017. The European Code of Conduct for Research Integrity (Revised Edition).
RCUK, 2017. Policy and Guidelines on Governance of Good Research Conduct.
UK Research Integrity Office, 2008. Procedure for the Investigation of Misconduct in Research.
University of Leeds, 2004. Protocol for investigating and resolving allegations of misconduct in academic research.
University of Portsmouth, 2013. Procedure for the Investigation of Allegations of Misconduct in Research.
23. Version Control
| Date Approved: February 2019 | Author: Research Integrity and Governance (RIG) Team, Research and Innovation Services (RIS) | Revision Date: February 2022 | |
| Version: | Revision Date: | Revised by: | Authorised by: |
| 1.0 | N/A | No previous versions. | University Executive Board |